Keyphrases
United Kingdom
66%
Whole Genome Sequencing
47%
Wales
47%
Vaccination
42%
COVID-19
41%
Invasive Pneumococcal Disease
34%
Confidence Interval
32%
Europe
31%
Neisseria Meningitidis
27%
Virus
25%
Influenza
23%
Immunogenicity
23%
Antimicrobial Resistance
23%
Escherichia Coli
21%
Vaccine Effectiveness
21%
Meningococcal Disease
20%
Men Who Have Sex with Men
20%
Conjugate Vaccine
20%
Quantitative PCR
19%
Epidemiology
18%
Neisseria Gonorrhoeae
18%
Genotype
16%
Age Groups
15%
Salmonella
15%
Antibody Response
15%
Serogroup
14%
Diphtheria
14%
Public Health England
14%
Core Genome multilocus Sequence Typing (cgMLST)
14%
Streptococcus Pneumoniae
13%
Risk Factors
13%
Sequence Type
13%
Serum Bactericidal Antibody
13%
Influenza Virus
12%
Plasmid
12%
Immunization
12%
Enterobacteriaceae
12%
Immune Response
12%
Influenza-like Illness
12%
Serogroup C
11%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
11%
Shiga Toxin-producing Escherichia Coli
11%
Norovirus
11%
β-lactamase
11%
Candida Auris
11%
Pertussis
11%
Revaccination
10%
4CMenB
10%
Surveillance Data
10%
Reference Laboratory
10%
Group A Streptococcus
10%
Seroprevalence
10%
Whole-genome Sequence Data
9%
Salmonella Enterica
9%
Human Immunodeficiency Virus Type 1 (HIV-1)
9%
Single nucleotide Polymorphism
9%
SARS-CoV-2 Infection
9%
Neutralizing Antibodies
9%
High-risk Human Papillomavirus (HR-HPV)
9%
Primary Care
9%
Genome Sequencing
9%
Group B Streptococcus
9%
Serovars
9%
Influenza Vaccine
9%
Molecular Epidemiology
8%
Cystic Fibrosis
8%
Meningitis
8%
Invasive Disease
8%
Laboratory Confirmation
8%
Antimicrobial Susceptibility
8%
COVID-19 Pandemic
8%
World Health Organization
8%
Listeria Monocytogenes
8%
European Countries
8%
Older Adults
8%
Polymerase Chain Reaction
8%
Oral Fluid
8%
Clonal Complex
8%
PCV7
8%
Chlamydia Trachomatis
8%
National Surveillance
8%
Hepatitis C Virus
8%
Streptococcus Pyogenes (S. pyogenes)
8%
H3N2
8%
Public Health
8%
Salmonella Typhi (S. Typhi)
8%
Odds Ratio
8%
Lymphogranuloma Venereum
8%
Pseudomonas Aeruginosa (P. aeruginosa)
8%
Enzyme-linked Immunosorbent Assay (ELISA)
8%
Measles
7%
Unvaccinated
7%
Meningococcal Serogroup B
7%
Haemophilus Influenzae Type b
7%
Azithromycin
7%
Adjuvanted
7%
Influenza A
7%
HPV16
7%
H1N1
7%
Gastroenteritis
7%
Immunology and Microbiology
Serotype
100%
Whole Genome Sequencing
39%
Influenza
37%
Neisseria meningitidis
32%
Antimicrobial Resistance
32%
Minimum Inhibitory Concentration
31%
Infectious Agent
30%
Virus
30%
Conjugate Vaccine
26%
Lineages
25%
Prevalence
24%
Immunogenicity
24%
Cladistics
23%
Escherichia coli
22%
Severe Acute Respiratory Syndrome Coronavirus 2
22%
Human Immunodeficiency Virus
19%
Bacterium Antibody
19%
Neisseria gonorrhoeae
16%
Plasmid
16%
Verotoxin-Producing Escherichia Coli
16%
Antibody Response
15%
Antibody Titer
15%
Influenza A Virus (H1N1)
14%
Streptococcus Pneumonia
13%
Single Nucleotide Polymorphism
13%
Salmonella
13%
Meningitis
13%
Immune Response
12%
Multilocus Sequence Typing
12%
Antibiotic Sensitivity
12%
Influenza Vaccine
12%
Escherichia Coli O157:H7
11%
Pneumococcal Vaccine
11%
Seroprevalence
11%
Real Time Polymerase Chain Reaction
11%
Bacteriophage
11%
Influenza Virus
11%
Titer
10%
COVID-19
10%
Norovirus
9%
Wart Virus
9%
Allele
9%
Enterobacteriaceae
9%
Viral Disease
8%
Neutralizing Antibody
8%
Immunoglobulin G
8%
Chlamydia Trachomatis
8%
Measles
8%
Meningococcal Vaccine
8%
Streptococcus Agalactiae
8%
Candida Auris
8%
Protein Binding
8%
Candida
7%
Klebsiella pneumoniae
7%
Influenza A Virus (H3N2)
7%
Genome Sequencing
7%
Streptococcus pyogenes
7%
Polymerase Chain Reaction
7%
Methicillin-Resistant Staphylococcus Aureus
7%
Salmonella enterica
7%
T Cell
7%
Spike
6%
Blood Plasma
6%
Wild Type
6%
Haemophilus Influenzae Type B
6%
Polysaccharide Vaccine
6%
Viral Load
6%
Human Immunodeficiency Virus 1
6%
ELISA
6%
Neutralization
6%
Gastroenteritis
6%
Factor H
6%
Neisseria
6%
Legionella pneumophila
6%
Broth Dilution
5%
Immunoassay
5%
Pseudomonas aeruginosa
5%
Staphylococcus Aureus
5%
Rubella
5%
Hemagglutinin
5%
Outer Membrane
5%
Neuraminidase Inhibitor
5%
Immunoassay
5%
Drug Resistance
5%
Enterobacterales
5%
Serology
5%
Agar Dilution
5%
Hepatitis C Virus
5%
Type Strain
5%
Human Papillomavirus Type 16
5%
Influenzavirus A
5%
Hemagglutination Inhibition
5%
Capsid
5%
Listeria monocytogenes
5%
Genetic Variability
5%
Molecular Epidemiology
5%
Medicine and Dentistry
Infection
74%
Serotype
54%
Diseases
43%
Severe Acute Respiratory Syndrome Coronavirus 2
32%
COVID-19
31%
Meningococcal Disease
28%
Public Health
28%
Human Immunodeficiency Virus
24%
Prevalence
22%
Antibiotic Resistance
18%
Whole Genome Sequencing
17%
Influenza Vaccine
17%
Neisseria meningitidis
16%
Men Who Have Sex with Men
16%
Cohort Effect
15%
Pathogen
13%
Pneumococcal Infection
13%
Virus
12%
Conjugate Vaccine
11%
Pneumococcus Vaccine
11%
Odds Ratio
11%
Primary Health Care
10%
Streptococcus Pneumonia
10%
Meningococcus Vaccine
9%
Cohort Analysis
9%
Pneumococcal Pneumonia
9%
Neisseria gonorrhoeae
8%
Cross Sectional Study
8%
Meningitis
8%
Immunogenicity
8%
Shiga Toxin Producing Escherichia Coli
8%
Randomized Controlled Trial
7%
Household
7%
Diphtheria
6%
Bloodstream Infection
6%
Pediatrics
6%
Typhoid Fever
6%
Azithromycin
6%
Hepatitis C
6%
Salmonella
6%
Salmonella Enterica Serovar Typhi
6%
Lymphogranuloma Venereum
6%
Influenza A Virus (H3N2)
5%
Polymerase Chain Reaction
5%
Pertussis
5%
Ciprofloxacin
5%
Influenza Vaccination
5%
Streptococcus Agalactiae
5%
Virus Infection
5%
Antibody Response
5%
Cohort Study
5%
Single Nucleotide Polymorphism
5%
Influenza A Virus (H1N1)
5%
Hepatitis C Virus
5%